TR200000900T2 - Ters termal jelasyon özellikleri olan biolojik olarak bozulabilen düşük moleküler ağırlıkta triblok poli(laktid-co-Glikolid)polietilen glikol kopolimerleri - Google Patents

Ters termal jelasyon özellikleri olan biolojik olarak bozulabilen düşük moleküler ağırlıkta triblok poli(laktid-co-Glikolid)polietilen glikol kopolimerleri

Info

Publication number
TR200000900T2
TR200000900T2 TR2000/00900T TR200000900T TR200000900T2 TR 200000900 T2 TR200000900 T2 TR 200000900T2 TR 2000/00900 T TR2000/00900 T TR 2000/00900T TR 200000900 T TR200000900 T TR 200000900T TR 200000900 T2 TR200000900 T2 TR 200000900T2
Authority
TR
Turkey
Prior art keywords
molecular weight
low molecular
glycolide
lactide
polyethylene glycol
Prior art date
Application number
TR2000/00900T
Other languages
English (en)
Inventor
Rathi Ramesh
M. Zentner Gaylen
Jeong Byeongmoon
Original Assignee
Macromed Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/943,167 external-priority patent/US6004573A/en
Priority claimed from US09/164,865 external-priority patent/US6117949A/en
Application filed by Macromed Inc. filed Critical Macromed Inc.
Publication of TR200000900T2 publication Critical patent/TR200000900T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00—Properties
    • C08L2201/06—Biodegradable
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/02—Organic macromolecular compounds, natural resins, waxes or and bituminous materials
    • C08L2666/14—Macromolecular compounds according to C08L59/00 - C08L87/00; Derivatives thereof
    • C08L2666/18—Polyesters or polycarbonates according to C08L67/00 - C08L69/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyethers (AREA)
  • Biological Depolymerization Polymers (AREA)

Abstract

Bu bulus suda çözülebilen düsük moleküle agirlikta, termo-duyarli, biyolojik olarak bozulabilir, hidrofobik bloklardan yüksek bir agirlik yüzdesine sahip olan blok kopolimerleri ve bunlarin parenteral, oküler, topikal, transdermal, vajinal, bukkal, transmukozal, pulmoner, transüretal, rektal, nazal, oral ya da aural ilaç uygulamalarindaki kullanimi ile ilgilidir.
TR2000/00900T 1997-10-03 1998-10-02 Ters termal jelasyon özellikleri olan biolojik olarak bozulabilen düşük moleküler ağırlıkta triblok poli(laktid-co-Glikolid)polietilen glikol kopolimerleri TR200000900T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/943,167 US6004573A (en) 1997-10-03 1997-10-03 Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US09/164,865 US6117949A (en) 1998-10-01 1998-10-01 Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties

Publications (1)

Publication Number Publication Date
TR200000900T2 true TR200000900T2 (tr) 2000-08-21

Family

ID=26860926

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00900T TR200000900T2 (tr) 1997-10-03 1998-10-02 Ters termal jelasyon özellikleri olan biolojik olarak bozulabilen düşük moleküler ağırlıkta triblok poli(laktid-co-Glikolid)polietilen glikol kopolimerleri

Country Status (15)

Country Link
EP (1) EP1034207B1 (tr)
JP (3) JP4656725B2 (tr)
KR (2) KR20010030891A (tr)
CN (1) CN1195788C (tr)
AR (1) AR015175A1 (tr)
AT (1) ATE290037T1 (tr)
AU (1) AU736812B2 (tr)
BR (1) BR9815239B1 (tr)
CA (1) CA2305621C (tr)
DE (1) DE69829204T2 (tr)
ES (1) ES2239408T3 (tr)
IL (2) IL135415A0 (tr)
PT (1) PT1034207E (tr)
TR (1) TR200000900T2 (tr)
WO (1) WO1999018142A1 (tr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6841617B2 (en) 2000-09-28 2005-01-11 Battelle Memorial Institute Thermogelling biodegradable aqueous polymer solution
US7087244B2 (en) 2000-09-28 2006-08-08 Battelle Memorial Institute Thermogelling oligopeptide polymers
WO2000000222A1 (en) * 1998-06-30 2000-01-06 Amgen Inc. Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents
WO2001041735A2 (en) * 1999-12-07 2001-06-14 Amgen Inc. Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
US6998137B2 (en) * 2000-04-07 2006-02-14 Macromed, Inc. Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
US7018645B1 (en) * 2000-04-27 2006-03-28 Macromed, Inc. Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
US6669959B1 (en) 2000-07-18 2003-12-30 Aeropharm Technology Incorporated Modulated release particles for lung delivery
PT1343530E (pt) * 2000-11-09 2007-09-25 Astrazeneca Ab Composição farmacêutica oral contendo um copolímero de blocos
US20030003074A1 (en) * 2001-06-14 2003-01-02 Macromed, Inc. Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
KR100527291B1 (ko) * 2001-07-14 2005-11-09 주식회사 삼양사 약물 전달체용 양이온기-함유 양친성 블록 공중합체 및그의 음이온성 약물과의 복합체
JP4346441B2 (ja) * 2001-11-15 2009-10-21 バイオマテラ インコーポレイテッド ゲルの調製方法
TW200307011A (en) * 2002-04-18 2003-12-01 Chugai Pharmaceutical Co Ltd Hyaluronic acid modifier
FR2840614B1 (fr) 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
US20040147532A1 (en) 2002-10-31 2004-07-29 Pfizer Inc Liquid conjugates of solid pharmaceuticals
FR2855521B1 (fr) 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
JP4735260B2 (ja) 2003-07-07 2011-07-27 日油株式会社 三元ブロック共重合体、その製造法及び生体内適合材料
FR2862535B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
FR2862541B1 (fr) * 2003-11-21 2007-04-20 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
EP1703895A2 (en) * 2004-01-13 2006-09-27 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
US20090023643A1 (en) * 2004-01-13 2009-01-22 Vasogenix Pharmaceuticals, Inc. Methods For Treating Acute Myocardial Infarction By Administering Calcitonin Gene Related Peptide And Compositions Containing The Same
EP1555278A1 (en) 2004-01-15 2005-07-20 Innocore Technologies B.V. Biodegradable multi-block co-polymers
JP2008517927A (ja) * 2004-10-21 2008-05-29 ユニバーシティー オブ アイオワ リサーチ ファンデーション ｉｎｓｉｔｕ制御放出薬剤送達システム
WO2007067624A2 (en) * 2005-12-06 2007-06-14 Tyco Healthcare Group Lp Bioabsorbable compounds and compositions containing them
CN101410114B (zh) 2006-01-26 2012-07-04 美国政府卫生与公共服务部 A3腺苷受体别构调节剂
JP5019851B2 (ja) * 2006-11-09 2012-09-05 学校法人 関西大学 温度応答性ゾル−ゲル転移を示す生分解性ポリマー及びその製造方法
US8871242B2 (en) 2006-11-17 2014-10-28 National Cerebral And Cardiovascular Center Blood anticoagulant material, coating material and indwelling device comprising the same, and treatment using blood anticoagulant material
HUE025842T2 (en) 2007-02-15 2016-04-28 Tolmar Therapeutics Inc Poly (lactide / glycolide) with reduced fracture properties and methods for producing polymers
FR2915683B1 (fr) 2007-05-03 2009-08-07 Flamel Technologies Sa Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
CN101333295B (zh) * 2007-06-27 2011-01-05 中国科学院化学研究所 一种生物可降解高分子纳米粒子及其专用聚合物和它们的制备方法
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
FR2919188B1 (fr) * 2007-07-27 2010-02-26 Proteins & Peptides Man Complexes entre un polymere amphiphile et une proteine osteogenique appartenant a la famille des bmps
US8642062B2 (en) 2007-10-31 2014-02-04 Abbott Cardiovascular Systems Inc. Implantable device having a slow dissolving polymer
JP4824710B2 (ja) * 2008-02-08 2011-11-30 国立清華大学 グラフト共重合体およびブロック共重合体の多機能混合ミセルならびにその製造方法
US8916188B2 (en) 2008-04-18 2014-12-23 Abbott Cardiovascular Systems Inc. Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
JP5814793B2 (ja) * 2008-11-25 2015-11-17 エコール ポリテクニク フェデラル ド ローザンヌ（エーペーエフエル） ブロックコポリマーおよびその使用
DK2478066T3 (en) * 2009-09-18 2017-06-19 Protherics Medicines Dev Ltd BAB TRIBLOCK POLYMERS WITH IMPROVED DELIVERY CHARACTERISTICS
EP2382966A1 (en) * 2010-03-12 2011-11-02 DSM IP Assets B.V. Micelle compositions and process for the preparation thereof
RU2617057C2 (ru) * 2010-03-26 2017-04-19 Евоник Корпорейшн Эмульсии для микрокапсулирования, содержащие биоразлагаемые поверхностно-активные блок-сополимеры в качестве стабилизаторов
CN102058909A (zh) * 2011-01-18 2011-05-18 复旦大学 聚乙二醇－共聚酯嵌段共聚物防粘连材料及其制备方法与应用
CN102181048B (zh) * 2011-03-11 2015-02-25 上海谊众生物技术有限公司 一种生物医用聚醚/聚酯嵌段共聚物的制备方法
CN102218027B (zh) * 2011-04-22 2014-07-02 上海谊众生物技术有限公司 一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂
EP2596802A1 (en) 2011-11-23 2013-05-29 PLS-Design GmbH Pharmaceutical composition for treatment of allergic reactions
ES2706149T3 (es) * 2012-02-08 2019-03-27 Toray Industries Material sensible a estímulos y material médico que lo comprende
EP2674167A1 (en) 2012-06-14 2013-12-18 PLS-Design GmbH Controlled activation of complement components for use as endogenous adjuvant
EP2674168A1 (en) 2012-06-14 2013-12-18 PLS-Design GmbH Modulation of effector T cell responses by local depletion of complement component C3
JP6119608B2 (ja) * 2012-09-24 2017-04-26 東レ株式会社 ブロック共重合体の製造方法
CN103772686B (zh) 2012-10-26 2015-01-07 苏州雷纳药物研发有限公司 一种两亲性嵌段共聚物及其制备方法、以及该共聚物与抗肿瘤药物形成的胶束载药系统
EP2746396A1 (en) 2012-12-20 2014-06-25 PLS-Design GmbH Selective local inhibition of TNFR1-mediated functions at the site of antigen/allergen presentation
CN103611196B (zh) * 2013-04-17 2015-09-16 苏州工业园区汉德医院投资管理有限公司 一种pela/bmp-2微球及其制备方法
JP6176998B2 (ja) * 2013-05-13 2017-08-09 学校法人 関西大学 温度応答性生分解性高分子組成物及びその製造方法
CN104689380A (zh) * 2013-12-10 2015-06-10 复旦大学 一种由物理交联水凝胶构成的黏膜下注射材料及其应用
CN103819905B (zh) * 2014-03-07 2016-01-20 山东理工大学 一种用聚三亚甲基碳酸酯与聚乙烯吡咯烷酮对聚肽膜亲水性进行改进的方法
EP2918262B1 (en) 2014-03-10 2023-08-09 PLS-Design GmbH Induction of antigen-specific tolerance by peripheral phagocytosis
CN104693431A (zh) * 2014-12-01 2015-06-10 周益峰 一种三嵌段聚合物及其制备方法和应用
US10398742B2 (en) 2014-12-15 2019-09-03 The Johns Hopkins University CVS transplantation for treatment of bacterial vaginosis
CN104606129B (zh) * 2015-01-21 2018-05-04 中国人民解放军广州军区武汉总医院 罗哌卡因长效注射用温敏凝胶及其制备方法
CN107635545A (zh) 2015-01-27 2018-01-26 约翰霍普金斯大学 用于增强粘膜表面处活性剂的输送的低渗水凝胶制剂
JP6584868B2 (ja) * 2015-02-25 2019-10-02 学校法人 関西大学 ゲル素材及びその製造方法
EP3095440B1 (en) 2015-05-19 2020-01-15 PLS-Design GmbH Antigen-specific immunotherapy using tolerizing liposomes
JP6886402B2 (ja) * 2015-08-24 2021-06-16 株式会社スリー・ディー・マトリックス 生分解性インジェクタブルゲル
CN105878174B (zh) * 2016-04-26 2021-06-29 广州帝奇医药技术有限公司 一种固体分散体及其制备方法与应用
CN106349466B (zh) * 2016-09-02 2019-09-20 广东众生药业股份有限公司 一种新的生物医用聚醚/聚酯嵌段共聚物的制备方法
EP3600437A4 (en) * 2017-03-31 2021-01-06 Rowan University OPTICALLY CLEAR IN-SITU EDUCATION OF BIODEGRADABLE NANOCARRIERS FOR EYE THERAPY AND THE SAME USING METHOD
SG11201909997VA (en) * 2017-04-28 2019-11-28 Evonik Degussa Gmbh Biodegradable bone glue
EP3787670A1 (en) 2017-10-18 2021-03-10 Luxembourg Institute of Health (LIH) Induction of allergen-specific tregs prior to oral or sublingual immunotherapy of food allergy
WO2019076478A1 (en) 2017-10-18 2019-04-25 Luxembourg Institute Of Health (Lih) OLIGODESOXYNUCLEOTIDES INCORPORATED IN HYDROGEL AS TOLEROGENEOUS ADJUVANT FOR SUB-CUTANEOUS IMMUNOTHERAPY
CN109498804B (zh) * 2018-12-04 2022-07-26 中国人民解放军军事科学院军事医学研究院 一种温度响应型狂犬疫苗递送系统
EP3679928A1 (fr) * 2019-01-08 2020-07-15 Atlangram Composition pharmaceutique de type gel pour traiter/prevenir une infection
CN110669184B (zh) * 2019-10-16 2022-05-31 临沂大学 一种具有药物释放功能的形状记忆高分子材料的制备方法及所得产品和应用
US20240024231A1 (en) * 2020-10-01 2024-01-25 Standard Millox Pharmaceuticals Oy Hydrogel material
GB202103785D0 (en) * 2021-03-18 2021-05-05 UCB Biopharma SRL Formulations
CN114699566B (zh) * 2022-04-08 2022-12-20 海泽临床成果转化医学研究院(无锡)有限公司 一种可吸收结扎夹的制备方法
JP2025529967A (ja) * 2023-04-03 2025-09-09 エルジー・ケム・リミテッド ポリエステルポリオール共重合体およびポリエステルポリオール共重合体の製造方法
CN117547654B (zh) * 2023-12-04 2024-06-21 上海长征医院 一种仿生负载rhBMP-2骨修复材料及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058081T3 (es) * 1986-09-05 1994-11-01 American Cyanamid Co Poliesteres que contienen bloques de oxido de alquileno como sistemas de administracion de medicamentos.
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
FR2741628B1 (fr) * 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
JP2001517603A (ja) * 1997-08-08 2001-10-09 ユニバーシティ オブ ユタ リサーチ ファウンデイション 薬物送達における使用のための注射可能な生分解性ブロックコポリマーゲル

Also Published As

Publication number Publication date
KR20010030891A (ko) 2001-04-16
CA2305621C (en) 2009-01-20
CN1195788C (zh) 2005-04-06
EP1034207A4 (en) 2002-04-17
ATE290037T1 (de) 2005-03-15
JP4903256B2 (ja) 2012-03-28
DE69829204D1 (en) 2005-04-07
KR100633939B1 (ko) 2006-10-16
AU9678098A (en) 1999-04-27
EP1034207B1 (en) 2005-03-02
BR9815239B1 (pt) 2010-07-13
EP1034207A1 (en) 2000-09-13
KR20010030889A (ko) 2001-04-16
CA2305621A1 (en) 1999-04-15
ES2239408T3 (es) 2005-09-16
IL135415A (en) 2008-04-13
PT1034207E (pt) 2005-07-29
IL135415A0 (en) 2001-05-20
HK1031736A1 (en) 2001-06-22
AU736812B2 (en) 2001-08-02
DE69829204T2 (de) 2005-12-15
AR015175A1 (es) 2001-04-18
CN1282345A (zh) 2001-01-31
JP2010144178A (ja) 2010-07-01
BR9815239A (pt) 2001-12-11
JP2012012606A (ja) 2012-01-19
JP2002516910A (ja) 2002-06-11
JP4656725B2 (ja) 2011-03-23
WO1999018142A1 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
TR200000900T2 (tr) Ters termal jelasyon özellikleri olan biolojik olarak bozulabilen düşük moleküler ağırlıkta triblok poli(laktid-co-Glikolid)polietilen glikol kopolimerleri
TR200100900T2 (tr) Ters ısıl jelasyon özellikleri olan, düşük moleküler ağırlığa sahip ve biyolojik olarak parçalanabilir triblok polyester polietilen glikol kopolimerleri
PT1141079E (pt) Copolímeros de tribloco de poliéster, polietilenoglicol, de baixo peso molecular, biodegradáveis, com propriedades de gelificação térmica inversa
CY1107540T1 (el) Μiγματα τρι-αδρομepων πολυεστepοπολυαιθυλενογλυκολης
Yanjarappa et al. Recent developments in the synthesis of functional poly (olefin) s
BRPI0514489A (pt) copolìmeros em dibloco biodegradáveis que têm propriedades de gelificação térmica reversa e processos de uso dos mesmos
EP1392751A4 (en) BIODEGRADABLE COPOLYMERS BONDED TO A SEGMENT WITH MULTIPLE FUNCTIONAL GROUPS
PT1143929E (pt) Hidrogeles biodegradaveis sensiveis ao ph e ao calor para a libertacao prolongada de agentes biologicamente activos
ATE265497T1 (de) Hydrierte blockcopolymerzusammensetzungen und verwendungen davon
DE60020710D1 (de) Hydrierte blockcopolymerzusammensetzungen und verwendungen davon
DE60021716D1 (de) Blockcopolymer und antistatisches mittel dieses enthaltend
ATE510885T1 (de) Hydrierte blockcopolymere mit elastischen eigenschaften und daraus hergestellte artikel
EP1365716A4 (en) BIODEGRADABLE CATIONIC POLY (ALKYLENIMINE) AND POLY (ETHYLENE GLYCOL) COPOLYMERS FOR THE DISTRIBUTION OF BIOACTIVE AGENTS
NO982063D0 (no) Polymere sammensetninger og fremgangsmÕte for bruk i lavtemperatur-br÷nnanvendelser
EP1548037A3 (de) Random-Propylen-Ethylencopolymere
DE69933544D1 (de) Polymer und härtbare zusammensetzung
IS5995A (is) Þríhringja hindrar fyrir pólý (ADP-róbósa) fjölliðara
AU2002215384A1 (en) Hydroxyapatite-targeting poly(ethylene glycol) and related polymers
SE8902867D0 (sv) Periodontium-regenerative materials
ATE339896T1 (de) Biologisch abbaubare kaugummigrundmasse
DE60111147D1 (de) Gummi aus EPDM mit hohem und niedrigem Molekulargewicht
DE69800945D1 (de) Blockcopolymere auf Basis von Polyisobutylen und Polydimethylsiloxan
DE60012825D1 (de) Harzartige Polymere aus Limonen, Dimethyldicyclopentadien, Inden und Vinyltoluol
ATE348121T1 (de) Polymere und ihre verwendungen
BR0309714A (pt) copolìmeros de aminoácidos e métodos de produção dos mesmos